Fusion Antibodies PLC

FAB

Company Profile

  • Business description

    Fusion Antibodies PLC offers various antibody engineering services for all therapeutic and diagnostic antibody development stages. It is engaged in the research, development, and manufacturing of recombinant proteins, particularly in cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression. Geographically company generates the majority of its revenue from North America.

  • Contact

    1 Springbank Road
    Springbank Industrial Estate, Dunmurry
    BelfastBT17 0QL
    GBR

    T: +44 2890432800

    E: [email protected]

    https://www.fusionantibodies.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2026

    Employees

    24

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries7,847.60205.10-2.55%
CAC 407,453.69145.29-1.91%
DAX 4021,220.01497.38-2.29%
Dow JONES (US)40,545.931,679.39-3.98%
FTSE 1008,319.53155.21-1.83%
HKSE22,849.81352.72-1.52%
NASDAQ16,550.611,050.44-5.97%
Nikkei 22533,780.58955.35-2.75%
NZX 50 Index12,225.28113.29-0.92%
S&P 5005,396.52274.45-4.84%
S&P/ASX 2007,667.80191.90-2.44%
SSE Composite Index3,342.018.12-0.24%

Market Movers